BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 31507601)

  • 1. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
    Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E
    Front Immunol; 2021; 12():625165. PubMed ID: 33777007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
    Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
    Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.
    Arruda LCM; Gaballa A; Uhlin M
    Blood Adv; 2019 Nov; 3(21):3436-3448. PubMed ID: 31714966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
    Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
    J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gamma delta T cells in haematopoietic stem cell transplantation.
    Minculescu L; Sengeløv H
    Scand J Immunol; 2015 Jun; 81(6):459-68. PubMed ID: 25753378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia.
    Klyuchnikov E; Badbaran A; Massoud R; Fritsche-Friedland U; Janson D; Ayuk F; Wolschke C; Bacher U; Kröger N
    Transplant Cell Ther; 2021 Oct; 27(10):841-850. PubMed ID: 34118468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications.
    Hu Y; Cui Q; Luo C; Luo Y; Shi J; Huang H
    Blood Rev; 2016 May; 30(3):179-88. PubMed ID: 26654098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.
    Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
    Minculescu L; Fischer-Nielsen A; Haastrup E; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Sengelov H; Marquart HV
    Front Immunol; 2020; 11():1068. PubMed ID: 32547559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
    Zaghi E; Calvi M; Di Vito C; Mavilio D
    Front Immunol; 2019; 10():2794. PubMed ID: 31849972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
    Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
    J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell-depleted grafts and the clinical implication of γδ T cells.
    Park M; Im HJ; Lee YJ; Park N; Jang S; Kwon SW; Park CJ; Choi ES; Koh KN; Seo JJ
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29090489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
    de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1152-1162. PubMed ID: 29505821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
    Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
    Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.
    Rådestad E; Sundin M; Törlén J; Thunberg S; Önfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
    Front Immunol; 2019; 10():189. PubMed ID: 30804948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.